Table 2.

Factors associated with 25,OH vitamin D in the SERA case-control study, 2002–07.

Characteristic25,OH Vitamin D, ng/ml,Unadjusted pAdjusted p
N (%)Mean (SD)
Sex
  Male68 (30)25.04 (8.91)ReferentReferent
  Female162 (70)26.21 (9.51)0.370.31
Taking a supplement containing vitamin D
  Yes157 (68)26.51 (8.8)ReferentReferent
  No73 (32)24.47 (10.34)0.140.15
Body mass index (BMI) category (missing for 6 participants)
  Normal (18.5–24.9)100 (43)26.89 (9.75)ReferentReferent
  Overweight (25–29.9)70 (31)26.39 (8.88)0.570.52
  Obese (30+)44 (19)21.47 (8.19)0.0010.003
Smoking
  None151 (66)26.88 (9.41)ReferentReferent
  1–19 pack-yrs69 (30)24.93 (8.72)0.100.08
  20+ pack-yrs10 (4)17.17 (8.16)0.0010.002
Season of blood draw (%)
  Warm months (Apr–Sep)117 (51)27.92 (9.51)ReferentReferent
  Cold months (Oct–Mar)113 (49)23.70 (8.69)0.00050.0002
Race/ethnicity (%)
  Non-Hispanic white200 (87)26.31 (9.26)ReferentReferent
  Black13 (6)21.23 (9.91)0.060.05
  Hispanic13 (6)27.00 (7.82)0.780.91
  Other4 (1)14.45 (7.66)0.010.03
Site of recruitment (%)
  Denver185 (80)26.06 (9.08)ReferentReferent
  Los Angeles18 (8)29.06 (11.74)0.190.12
  Nebraska8 (2)26.50 (10.65)0.90.37
  Seattle19 (8)19.94 (7.76)0.0070.04
  • Adjusted for all other variables, in addition to case status. Vitamin D supplement included individuals taking a multivitamin supplement, vitamin D supplement, or vitamin D supplement with calcium.